Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicentric Study for the Treatment of Children With Acute Lymphoblastic Leukemia
NCT00343369Phase 3Unknown
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jan 2003
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of daunorubicin, doxorubicin, methotrexate, pegaspargase, asparaginase escherichia coli in acute lymphoblastic leukemia (ALL), sponsored by University Medical Center Hamburg-Eppendorf. Status: unknown.
02
Drugs
daunorubicindoxorubicinmethotrexatepegaspargaseasparaginase escherichia coli
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00343369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343369.